Identification of a new class of small molecule C5a receptor antagonists
- 15 January 2010
- journal article
- research article
- Published by Elsevier in Bioorganic & Medicinal Chemistry Letters
- Vol. 20 (2), 662-664
- https://doi.org/10.1016/j.bmcl.2009.11.058
Abstract
No abstract availableKeywords
This publication has 22 references indexed in Scilit:
- Identification and Characterization of NDT 9513727 [N,N-bis(1,3-Benzodioxol-5-ylmethyl)-1-butyl-2,4-diphenyl-1H-imidazole-5-methanamine], a Novel, Orally Bioavailable C5a Receptor Inverse AgonistJournal of Pharmacology and Experimental Therapeutics, 2008
- Design and optimization of aniline-substituted tetrahydroquinoline C5a receptor antagonistsBioorganic & Medicinal Chemistry Letters, 2008
- Locally Produced Complement Fragments C5a and C3a Provide Both Costimulatory and Survival Signals to Naive CD4+ T CellsImmunity, 2008
- Complement regulates inhalation tolerance at the dendritic cell/T cell interfaceMolecular Immunology, 2007
- Local application of FTY720 to the lung abrogates experimental asthma by altering dendritic cell functionJCI Insight, 2006
- C5a Receptor Deficiency Attenuates T Cell Function and Renal Disease in MRLlpr MiceJournal of the American Society of Nephrology, 2005
- The dark side of C5a in sepsisNature Reviews Immunology, 2004
- Essential Role for the C5a Receptor in Regulating the Effector Phase of Synovial Infiltration and Joint Destruction in Experimental ArthritisThe Journal of Experimental Medicine, 2002
- Identification of a Potent and Orally Active Non-peptide C5a Receptor AntagonistPublished by Elsevier ,2002
- Arthritis Critically Dependent on Innate Immune System PlayersImmunity, 2002